NCT05196828 - Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS | Biotech Hunter

Enrollment

103

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

September 27, 2022

Study Completion Date

November 18, 2022

Conditions

Restless Legs Syndrome

Interventions

DEVICE

NTX100 Neuromodulation System

Active Noninvasive peripheral nerve stimulation device programmed to active mode

Trial Locations (7)

Bogan Sleep Consultants, LLC, Columbia

Neurotrials Research, Atlanta

Ohio Sleep Medicine Institute, Dublin

Clayton Sleep Institute, St Louis

FutureSearch Trials of Neurology, Austin

California Center for Sleep Disorders, San Leandro

Delta Waves, Inc., Colorado Springs